BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
16 results:

  • 1. Development and validation of a preoperative risk nomogram prediction model for gastric gastrointestinal stromal tumors.
    Liu Z; Gao J; Zeng C; Chen Y
    Surg Endosc; 2024 Apr; 38(4):1933-1943. PubMed ID: 38334780
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
    Grosser B; Emmerson J; Reitsam NG; Cunningham D; Nankivell M; Langley RE; Allum WH; Trepel M; Märkl B; Grabsch HI
    Br J Cancer; 2024 Feb; 130(3):457-466. PubMed ID: 38123705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]    [Full Text] [Related]  

  • 4. Predictive Value of a Radiomics Nomogram Model Based on Contrast-Enhanced Computed Tomography for KIT Exon 9 Gene Mutation in Gastrointestinal Stromal Tumors.
    Wei Y; Lu Z; Ren Y
    Technol Cancer Res Treat; 2023; 22():15330338231181260. PubMed ID: 37296525
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Optimizing prognostic factors of five-year survival in gastric cancer patients using feature selection techniques with machine learning algorithms: a comparative study.
    Afrash MR; Mirbagheri E; Mashoufi M; Kazemi-Arpanahi H
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):54. PubMed ID: 37024885
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Influence of the Elipse Intragastric Balloon on Obesity and Metabolic Profile: A Systematic Review and Meta-Analysis.
    Ramai D; Singh J; Mohan BP; Madedor O; Brooks OW; Barakat M; Ofosu A; Khan SR; Chandan S; Dhindsa B; Dhaliwal A; Facciorusso A; McDonough S; Adler DG
    J Clin Gastroenterol; 2021 Nov-Dec 01; 55(10):836-841. PubMed ID: 33394629
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EndoPil: A Magnetically Actuated Swallowable Capsule for Weight Management: Development and Trials.
    Phan PT; Tiong AMH; Miyasaka M; Cao L; Kaan HL; Ho KY; Phee SJ
    Ann Biomed Eng; 2021 May; 49(5):1391-1401. PubMed ID: 33215368
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
    Kim YY; Lee J; Jeong WK; Kim ST; Kim JH; Hong JY; Kang WK; Kim KM; Sohn I; Choi D
    Gastric Cancer; 2021 Mar; 24(2):457-466. PubMed ID: 32970267
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Robotic-assisted modified retroauricular cervical approach: initial experience in Latin America.
    Chulam TC; Lira RB; Kowalski LP
    Rev Col Bras Cir; 2016; 43(4):289-91. PubMed ID: 27679950
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway.
    Kong GM; Tao WH; Diao YL; Fang PH; Wang JJ; Bo P; Qian F
    World J Gastroenterol; 2016 Mar; 22(11):3186-95. PubMed ID: 27003995
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.
    Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A;
    Ann Oncol; 2014 Jul; 25(7):1373-1378. PubMed ID: 24728035
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.
    Oba K; Paoletti X; Alberts S; Bang YJ; Benedetti J; Bleiberg H; Catalano P; Lordick F; Michiels S; Morita S; Ohashi Y; Pignon JP; Rougier P; Sasako M; Sakamoto J; Sargent D; Shitara K; Cutsem EV; Buyse M; Burzykowski T;
    J Natl Cancer Inst; 2013 Nov; 105(21):1600-7. PubMed ID: 24108812
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Informed consent in the intragastric balloon supported by SENPE, SEEDO, SEN and SECO: legal aspects].
    Abilés V; Martínez Olmos MA; Escartí MA; Bretón I; Cáncer E; Pelaez N; Álvarez V; Culebras JM; Mazure RA;
    Nutr Hosp; 2012; 27(2):419-24. PubMed ID: 22732963
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
    Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
    Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
    Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
    Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.